Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Azienda Sanitaria Universitaria Friuli Centrale
Sponsor

Azienda Sanitaria Universitaria Friuli Centrale

Italy Piazzale Santa Maria Della Misericordia 15, 33100 Udine, Italy

About the sponsor

Clinical research activity includes evaluation of piperacillin/tazobactam administration in infectious disease care, with attention to treatment delivery in hospital-based settings and the management of serious bacterial infections.

  • Antibiotic pharmacokinetics
  • Hospital infection treatment
  • Parenteral-to-subcutaneous administration

The sponsor’s work in this area is centered on practical antimicrobial use within acute care pathways.

About Specializations

Azienda Sanitaria Universitaria Friuli Centrale runs clinical trials in conditions such as Bacterial infection, Hypotension, Psoriatic arthropathy, Acute respiratory distress syndrome, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

4 clinical trials

Bacterial infection

Recruiting

Study of Piperacillin and Tazobactam Given Under the Skin Compared to a Vein in Patients with Infectious Diseases

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Piperacillin
  • Sponsor:Azienda Sanitaria Universitaria Friuli Centrale

Hypotension

Recruiting

Testing Bisoprolol in Patients with Acute or Recurrent Pericarditis to Reduce Symptoms and Prevent Recurrence

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bisoprolol
  • Sponsor:Azienda Sanitaria Universitaria Friuli Centrale

Psoriatic arthropathy

Not yet recruiting

A Study of Guselkumab and Ciclosporin in Patients with Early Psoriatic Arthritis Transitioning from Skin to Joint Disease

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Ciclosporin
  • Sponsor:Azienda Sanitaria Universitaria Friuli Centrale

Acute respiratory distress syndrome

Not yet recruiting

Study on Anakinra for Patients with Non-COVID-19 Related Acute Respiratory Distress Syndrome (ARDS)

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Anakinra
  • Sponsor:Azienda Sanitaria Universitaria Friuli Centrale

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.